Form DEFR14C - Revised information statement materials, definitive:
SEC Accession No. 0001013596-10-000068
Filing Date
2010-06-21
Accepted
2010-06-21 16:23:59
Documents
2
Effectiveness Date
2010-06-21

Document Format Files

Seq Description Document Type Size
1 REVISED DEFINITIVE SCHEDULE 14C def14c-rev.htm DEFR14C 93091
2 filename2.htm CORRESP 11130
  Complete submission text file 0001013596-10-000068.txt   105934
Mailing Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2
Business Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2 514-496-5197
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEFR14C | Act: 34 | File No.: 000-52898 | Film No.: 10908239
SIC: 8742 Services-Management Consulting Services